Catalent Appoints Shannon Trilli in Move to Strengthen its Corporate Responsibility Initiatives
Somerset, N.J. (PRWEB) November 17, 2016 -- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the appointment of Ms. Shannon Trilli in the newly created role of Director of Corporate Responsibility.
In her post, Ms. Trilli will be responsible for implementing Catalent’s global corporate responsibility strategy. She will strengthen Catalent’s efforts in this area, which will continue to be led by its Corporate Responsibility Council, composed of senior Catalent leaders from multiple functions. Ms. Trilli will coordinate and organize Catalent’s existing initiatives in sustainability and maximizing social impact, and its employee-driven community programs. She will also lead Catalent’s activities in establishing additional programs, including the matching of gifts and strategic volunteer initiatives, and the expansion of the organization’s philanthropic and partnership portfolio.
Before joining Catalent, she served as the Director of Corporate Responsibility at S&P Global, a leading provider of transparent and independent ratings, benchmarks, analytics and data to capital and commodity markets worldwide.
Prior to S&P Global, Ms. Trilli acted as the Director of Global Health for the United Methodist Committee on Relief (UMCOR). There, she designed, scaled and led UMCOR's Signature Health Program to provide funding and technical support to community based health organizations. She also led its $75 million "Imagine No Malaria" program in sub-Saharan Africa, with partners such as the U.N. Foundation and The Global Fund.
Ms. Trilli has also served as a micro-enterprise development Peace Corps volunteer in Bolivia, and early in her career, was the manager of Global Employee Programs for the Contributions and Community Relations unit of The McGraw-Hill Companies.
"In addition to more deeply engaging our communities and demonstrating Catalent's commitment to and improving health and the environment, Shannon’s appointment and implementation of the corporate responsibility strategy will help us more meaningfully connect to employees, customers, and stakeholders,” commented Alessandro Maselli, Catalent’s Senior Vice President of Global Operations. He added, “In her new role, she will help us effectively communicate how Catalent’s capabilities and values result in positive social and business impacts, both in our local communities and across the globe."
Ms. Trilli earned a bachelor's in government from the University of Texas in Austin, and a master's degree in public administration from New York University.
About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 9,500 people, including over 1,400 scientists, more than 30 facilities across five continents, and in fiscal 2016 generated $1.85 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com
More products. Better treatments. Reliably supplied.™
Chris Halling, Catalent Pharma Solutions, http://www.catalent.com, +44 7580041073, [email protected]
Share this article